InvestorsHub Logo
icon url

matt6314

06/28/13 6:35 AM

#7775 RE: fulcrumgavel #7774

fulcrum,

I say state naming them. That challenge has been out there for many months now. i do not have time to do that much research and if you already have the knowledge then lets hear them. I know they are out there.

I got my information from an article about the challenges of investing in pink sheet and how few do actually make it but they definitely do make it. That is what I want NNLX to do but it seems like the present regime has no idea how to get there and is learning at our expense. It could take a decade to get there if we do not get passed up by some other technology.

Time is of the essence but no one actually realizes it.
icon url

parentsgratae

06/28/13 9:20 AM

#7777 RE: fulcrumgavel #7774

You do not need my go ahead LOL; rail already researched this and stated to me that there were none that had achieved the listed accomplishments that NNLX has. I do believe our technology threatens the PCR industry and others now losing market share to institutions buying from us. fulcrumgavel, I will never forget your prior post about a technology study that surpassed ours when, in fact, what you did not disclose, is that 105 of the patients were excluded from the final analysis of the 968 that were included in the study. Over ten percent excluded; however, the TMC had included all; had the TMC study excluded the alleged "non-tests" our results would be even higher in sensitivity and specificity, so I supposes, if you can dissimulate on the French study, you can say just about anything.
Parents
icon url

exploremore

06/28/13 12:31 PM

#7779 RE: fulcrumgavel #7774

“this is just a cop out question”

Well said, who cares what any other companies are doing, so there is a bunch of junk on the pink sheets, this is starting to fit right in..